Pazopanib Supplier-Buyer Network — Trade Flow Analysis

Name: Pazopanib Supplier-Buyer Trade Network Dataset — 109+ Indian Exporters, 4+ Importers, 57+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Pazopanib supplier network, Pazopanib buyers, pharmaceutical export India, Pazopanib trade data

TransData Nexus

Pazopanib

India Pharmaceutical Trade Intelligence

$8.3M109 Suppliers57 CountriesHS 30049049

ExportsIndia → UNITED STATES84.4%India → GEORGIA2.6%

ImportsUNITED KINGDOM → India$3.3M SWITZERLAND → India$596.6K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: SUN PHARMACEUTICAL

Who Supplies Pazopanib? Top Manufacturers & Buyers 2026 — SUN PHARMACEUTICAL INDUSTRIES LIMITED Leads | TransData Nexus | TransData Nexus

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Pazopanib exporter from India, with a market share of 64.4% and a total export value of $5.4M across 9 shipments. Their average shipment value of $597.2K is above the market average of $16.8K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 2 named buyers in our database. SUN PHARMACEUTICAL INDUSTRIES,INC. is the dominant customer, accounting for 57.3% of this supplier's tracked business. Top customers include:

• SUN PHARMACEUTICAL INDUSTRIES,INC. — $3.1M across 5 shipments (57.3% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES,INC. — $2.3M across 4 shipments (42.7% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $597.2K is 3462% above the market average of $16.8K, consistent with large-order contracts or value-added formulations.

2SP ACCURE LABS PRIVATE LIMITED

SP ACCURE LABS PRIVATE LIMITED is the second-largest Pazopanib exporter from India, with a market share of 12.0% and a total export value of $1.0M across 6 shipments. Their average shipment value of $167.1K is above the market average of $16.8K, suggesting premium or bulk contract pricing.

SP ACCURE LABS PRIVATE LIMITED serves 1 named buyer in our database. SUN PHARMACEUTICAL INDUSTRIES,INC. is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• SUN PHARMACEUTICAL INDUSTRIES,INC. — $1.0M across 6 shipments (100.0% of this supplier's total exports)

Key Insight: SP ACCURE LABS PRIVATE LIMITED's per-shipment value of $167.1K is 897% above the market average of $16.8K, consistent with large-order contracts or value-added formulations.

3GNH INDIA PHARMACEUTICALS LIMITED

GNH INDIA PHARMACEUTICALS LIMITED is the third-largest Pazopanib exporter from India, with a market share of 3.4% and a total export value of $282.3K across 6 shipments. Their average shipment value of $47.1K is above the market average of $16.8K, suggesting premium or bulk contract pricing.

GNH INDIA PHARMACEUTICALS LIMITED serves 1 named buyer in our database. M/S.NOVUGEN ONCOLOGY SDN.BHD is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• M/S.NOVUGEN ONCOLOGY SDN.BHD — $282.3K across 6 shipments (100.0% of this supplier's total exports)

Key Insight: GNH INDIA PHARMACEUTICALS LIMITED's per-shipment value of $47.1K is 181% above the market average of $16.8K, consistent with large-order contracts or value-added formulations.

4TEYRO LABS PRIVATE LIMITED

TEYRO LABS PRIVATE LIMITED is the fourth-largest Pazopanib exporter from India, with a market share of 0.9% and a total export value of $74.0K across 6 shipments. Their average shipment value of $12.3K is below the market average of $16.8K, reflecting a high-volume, competitive pricing strategy.

TEYRO LABS PRIVATE LIMITED serves 1 named buyer in our database. TISHAS ADDITIONAL LIABILITY COMPANY is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• TISHAS ADDITIONAL LIABILITY COMPANY — $74.0K across 6 shipments (100.0% of this supplier's total exports)

Key Insight: TEYRO LABS PRIVATE LIMITED operates with high shipment frequency (6 shipments) at a per-shipment value of $12.3K, indicating a broad distribution network with many smaller, regular orders.

5MYGENIC HEALTHCARE PRIVATE LIMITED

MYGENIC HEALTHCARE PRIVATE LIMITED is the fifth-largest Pazopanib exporter from India, with a market share of 0.9% and a total export value of $73.7K across 21 shipments. Their average shipment value of $3.5K is below the market average of $16.8K, reflecting a high-volume, competitive pricing strategy.

MYGENIC HEALTHCARE PRIVATE LIMITED serves 1 named buyer in our database. 142 DAVIT AGHMASHENE is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• 142 DAVIT AGHMASHENE — $73.7K across 21 shipments (100.0% of this supplier's total exports)

Key Insight: MYGENIC HEALTHCARE PRIVATE LIMITED operates with high shipment frequency (21 shipments) at a per-shipment value of $3.5K, indicating a broad distribution network with many smaller, regular orders.

6BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED

BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the fifth-largest Pazopanib exporter from India, with a market share of 0.0% and a total export value of $0 across 3 shipments. Their average shipment value of $0 is below the market average of $16.8K, reflecting a high-volume, competitive pricing strategy.

Key Insight: BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED operates with high shipment frequency (3 shipments) at a per-shipment value of $0, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Pazopanib imports from India, with a total trade value of $7.0M across 15 shipments — representing a 84.4% share of all Pazopanib exports. The average shipment value of $470.0K is above the global average of $16.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Pazopanib importers in United States: SUN PHARMACEUTICAL INDUSTRIES INC is the largest buyer, accounting for 46.8% ($3.3M) of this market's total imports.

• SUN PHARMACEUTICAL INDUSTRIES INC — $3.3M (46.8% of United States's total)

• SUN PHARMACEUTICAL INDUSTRIES,INC. — $3.3M (46.3% of United States's total)

• M/S.NOVUGEN ONCOLOGY SDN.BHD — $282.3K (4.0% of United States's total)

Key Insight: United States's per-shipment average of $470.0K (2703% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Pazopanib imports from India.

Primary Market

Secondary Market

2Georgia

Georgia ranks as the second-largest destination for Pazopanib imports from India, with a total trade value of $212.9K across 7 shipments — representing a 2.6% share of all Pazopanib exports. The average shipment value of $30.4K is above the global average of $16.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Pazopanib importers in Georgia: 142 DAVIT is the largest buyer, accounting for 19.8% ($42.2K) of this market's total imports.

• 142 DAVIT — $42.2K (19.8% of Georgia's total)

• MERMISI LLC — $27.1K (12.8% of Georgia's total)

Key Insight: Georgia's per-shipment average of $30.4K (81% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Georgia is a key market for Pazopanib imports from India.

Primary Market

Secondary Market

3Taiwan

Taiwan ranks as the third-largest destination for Pazopanib imports from India, with a total trade value of $192.9K across 2 shipments — representing a 2.3% share of all Pazopanib exports. The average shipment value of $96.5K is above the global average of $16.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Pazopanib importers in Taiwan: LOTUS PHARMACEUTICAL CO.LTD., is the largest buyer, accounting for 100.0% ($192.9K) of this market's total imports.

• LOTUS PHARMACEUTICAL CO.LTD., — $192.9K (100.0% of Taiwan's total)

Key Insight: Taiwan's per-shipment average of $96.5K (475% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Taiwan is a key market for Pazopanib imports from India.

Primary Market

Secondary Market

4Sri Lanka

Sri Lanka ranks as the fourth-largest destination for Pazopanib imports from India, with a total trade value of $161.5K across 4 shipments — representing a 1.9% share of all Pazopanib exports. The average shipment value of $40.4K is above the global average of $16.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Pazopanib importers in Sri Lanka: STATE PHARMACEUTICALS CORPORATION is the largest buyer, accounting for 96.9% ($156.6K) of this market's total imports.

• STATE PHARMACEUTICALS CORPORATION — $156.6K (96.9% of Sri Lanka's total)

Key Insight: Sri Lanka's per-shipment average of $40.4K (141% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sri Lanka is a key market for Pazopanib imports from India.

Primary Market

Secondary Market

5Belarus

Belarus ranks as the fifth-largest destination for Pazopanib imports from India, with a total trade value of $150.1K across 2 shipments — representing a 1.8% share of all Pazopanib exports. The average shipment value of $75.0K is above the global average of $16.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Pazopanib importers in Belarus: TISHAS ADDITIONAL LIABILITY COMPANY is the largest buyer, accounting for 100.0% ($150.1K) of this market's total imports.

• TISHAS ADDITIONAL LIABILITY COMPANY — $150.1K (100.0% of Belarus's total)

Key Insight: Belarus's per-shipment average of $75.0K (348% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belarus is a key market for Pazopanib imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Pazopanib.
2.Flow Mapping: 109 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 498 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 57 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

498 Verified Shipments

109 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Pazopanib

Pazopanib

Who Supplies Pazopanib? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Pazopanib? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Pazopanib Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

2SP ACCURE LABS PRIVATE LIMITED

3GNH INDIA PHARMACEUTICALS LIMITED

4TEYRO LABS PRIVATE LIMITED

5MYGENIC HEALTHCARE PRIVATE LIMITED

6BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Pazopanib Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Pazopanib Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Georgia

3Taiwan

4Sri Lanka

5Belarus

People Also Ask — Pazopanib Supplier & Trade Network

Pazopanib Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology